BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 26617865)

  • 1. Expression of pyruvate kinase M2 in human colorectal cancer and its prognostic value.
    Cui R; Shi XY
    Int J Clin Exp Pathol; 2015; 8(9):11393-9. PubMed ID: 26617865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of regulator of G-protein signaling 6 in colorectal cancer.
    Luo Y; Qin SL; Yu MH; Mu YF; Wang ZS; Zhong M
    Biomed Pharmacother; 2015 Dec; 76():147-52. PubMed ID: 26653562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of Rab5A predicts metastasis and poor prognosis in colorectal cancer patients.
    Yu MH; Luo Y; Qin SL; Zhong M
    Int J Clin Exp Pathol; 2015; 8(6):6974-80. PubMed ID: 26261586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
    Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
    Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between KIAA1199 overexpression and tumor invasion, TNM stage, and poor prognosis in colorectal cancer.
    Xu J; Liu Y; Wang X; Huang J; Zhu H; Hu Z; Wang D
    Int J Clin Exp Pathol; 2015; 8(3):2909-18. PubMed ID: 26045799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Rab27A expression indicates favorable prognosis in CRC.
    Shi C; Yang X; Ni Y; Hou N; Xu L; Zhan F; Zhu H; Xiong L; Chen P
    Diagn Pathol; 2015 Jun; 10():68. PubMed ID: 26070933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gab2 is a novel prognostic factor for colorectal cancer patients.
    Ding C; Luo J; Yu W; Gao S; Yang L; Chen C; Feng J
    Int J Clin Exp Pathol; 2015; 8(3):2779-86. PubMed ID: 26045784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic correlation between MTA2 expression level and colorectal cancer.
    Ding W; Hu W; Yang H; Ying T; Tian Y
    Int J Clin Exp Pathol; 2015; 8(6):7173-80. PubMed ID: 26261611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of Y-box-binding protein 1 is associated with local recurrence and predicts poor outcome in patients with colorectal cancer.
    Yan X; Yan L; Zhou J; Liu S; Shan Z; Jiang C; Tian Y; Jin Z
    Int J Clin Exp Pathol; 2014; 7(12):8715-23. PubMed ID: 25674237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of PFTK1 in cancer cells predicts poor prognosis in colorectal cancer.
    Mao Y; Jia Y; Zhu H; Wang W; Jin Q; Huang F; Zhang S; Li X
    Mol Med Rep; 2017 Jul; 16(1):224-230. PubMed ID: 28498444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyruvate kinase type M2 is upregulated in colorectal cancer and promotes proliferation and migration of colon cancer cells.
    Zhou CF; Li XB; Sun H; Zhang B; Han YS; Jiang Y; Zhuang QL; Fang J; Wu GH
    IUBMB Life; 2012 Sep; 64(9):775-82. PubMed ID: 22807066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of phospho-mTOR kinase is abundant in colorectal cancer and associated with left-sided tumor localization.
    Melling N; Simon R; Izbicki JR; Terracciano LM; Bokemeyer C; Sauter G; Marx AH
    Int J Clin Exp Pathol; 2015; 8(6):7009-15. PubMed ID: 26261591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of ANO9 in stage II and III colorectal carcinoma.
    Li C; Cai S; Wang X; Jiang Z
    Oncotarget; 2015 Oct; 6(30):29324-34. PubMed ID: 26317553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of IRF-2 expression in colorectal cancer.
    Mei Z; Wang G; Liang Z; Cui A; Xu A; Liu Y; Liu C; Yang Y; Cui L
    Oncotarget; 2017 Jun; 8(24):38969-38977. PubMed ID: 28465494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of spondin-2 predicts poor survival of colorectal carcinoma patients.
    Zhang Q; Wang XQ; Wang J; Cui SJ; Lou XM; Yan B; Qiao J; Jiang YH; Zhang LJ; Yang PY; Liu F
    Oncotarget; 2015 Jun; 6(17):15095-110. PubMed ID: 25945835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of MUC1 and MUC3 in the biology and prognosis of colorectal cancer.
    Duncan TJ; Watson NF; Al-Attar AH; Scholefield JH; Durrant LG
    World J Surg Oncol; 2007 Mar; 5():31. PubMed ID: 17349047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of NETO2 expression correlates with tumor progression and poor prognosis in colorectal carcinoma.
    Hu L; Chen HY; Cai J; Yang GZ; Feng D; Zhai YX; Gong H; Qi CY; Zhang Y; Fu H; Cai QP; Gao CF
    BMC Cancer; 2015 Dec; 15():1006. PubMed ID: 26699544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low expression of B-Cell-Associated protein 31 is associated with unfavorable prognosis in human colorectal cancer.
    Ma C; Jin RM; Chen KJ; Hao T; Li BS; Zhao DH; Jiang H
    Pathol Res Pract; 2018 May; 214(5):661-666. PubMed ID: 29653744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of Hexokinase 1 as a poor prognosticator in human colorectal cancer.
    He X; Lin X; Cai M; Zheng X; Lian L; Fan D; Wu X; Lan P; Wang J
    Tumour Biol; 2016 Mar; 37(3):3887-95. PubMed ID: 26476538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of pyruvate kinase M2 predicts a poor prognosis for patients with osteosarcoma.
    Liu ZX; Hong L; Fang SQ; Tan GH; Huang PG; Zeng Z; Xia X; Wang XX
    Tumour Biol; 2016 Nov; 37(11):14923-14928. PubMed ID: 27644251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.